ELUT
Elutia Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.82
−2.24%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 18.19x
Trailing multiples
Trailing twelve months
- P/E TTM
- 0.63x
- PEG TTM
- —
- Price / book
- 2.31x
- Price / sales
- 3.00x
- Price / cash flow
- -0.83x
Enterprise value
- Enterprise value
- $27.3M
- EV / sales
- 2.25x
- EV / EBITDA
- -1.13x
- EV / EBIT
- -1.16x
- Market cap
- $36.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026